623 AI-designed personalized neoantigen vaccine, EVX-02, induces robust T-cell responses in melanoma patients

• Anders Jespersen,
• Daniela Kleine-Kohlbrecher,
• Nadia Viborg,
• Mads Lausen,
• Thomas Trolle,
• Michail A Pavlidis,
• Nikolas H Thuesen,
• Christian Garde,
• Thomas S Jepsen,
• Britt W Lauenborg,
• Birgitte Rønø

Affiliations

Anders Jespersen

Evaxion Biotech, Hoersholm, Zealand, Denmark

Daniela Kleine-Kohlbrecher

5Evaxion Biotech, Horsholm, Denmark

Nadia Viborg

6Evaxion Biotech, Hoersholm, Zealand, Denmark

Mads Lausen

Evaxion Biotech, Hoersholm, Zealand, Denmark

Thomas Trolle

6Evaxion Biotech, Hoersholm, Zealand, Denmark

Michail A Pavlidis

Evaxion Biotech, Hoersholm, Zealand, Denmark

Nikolas H Thuesen

Evaxion Biotech, Hoersholm, Zealand, Denmark

Christian Garde

Evaxion Biotech, Hoersholm, Zealand, Denmark

Thomas S Jepsen

Evaxion Biotech, Hoersholm, Zealand, Denmark

Britt W Lauenborg

Evaxion Biotech, Hoersholm, Zealand, Denmark

Birgitte Rønø

Evaxion Biotech, Hoersholm, Zealand, Denmark